Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic Substudy

医学 雷米普利 射血分数 心脏病学 内科学 心肌梗塞 缬沙坦 沙库比林、缬沙坦 沙库比林 心力衰竭 血管紧张素转换酶抑制剂 血管紧张素转换酶 血压
作者
Amil M. Shah,Brian Claggett,Narayana Prasad,Guichu Li,Mayra Volquez,Karola Jering,Maja Čikeš,Attila Kovács,Wilfried Mullens,José Carlos Nicolau,Lars Køber,Peter van der Meer,Pardeep S. Jhund,Ghionul Ibram,Martin Lefkowitz,Yinong Zhou,Scott D. Solomon,Marc A. Pfeffer
出处
期刊:Circulation [Lippincott Williams & Wilkins]
卷期号:146 (14): 1067-1081 被引量:30
标识
DOI:10.1161/circulationaha.122.059210
摘要

Background: Angiotensin-converting enzyme inhibitors attenuate left ventricular (LV) enlargement after acute myocardial infarction (AMI). Preclinical data suggest similar benefits with combined angiotensin receptor neprilysin inhibition, but human data are conflicting. The PARADISE-MI Echo Study (Prospective ARNI Versus ACE Inhibitor Trial to Determine Superiority in Reducing Heart Failure Events After Myocardial Infarction) tested the effect of sacubitril/valsartan compared with ramipril on LV function and adverse remodeling after high risk-AMI. Methods: In a prespecified substudy, 544 PARADISE-MI participants were enrolled in the Echo Study to undergo protocol echocardiography at randomization and after 8 months. Patients were randomized within 0.5 to 7 days of presentation with their index AMI to receive a target dose of sacubitril/valsartan 200 mg or ramipril 5 mg twice daily. Echocardiographic measures were performed at a core laboratory by investigators blinded to treatment assignment. The effect of treatment on change in echo measures was assessed with ANCOVA with adjustment for baseline value and enrollment region. The primary end points were change in LV ejection fraction (LVEF) and left atrial volume (LAV), and prespecified secondary end points included changes in LV end-diastolic and end-systolic volumes. Results: Mean age was 64±12 years; 26% were women; mean LVEF was 42±12%; and LAV was 49±17 mL. Of 544 enrolled patients, 457 (84%) had a follow-up echo at 8 months (228 taking sacubitril/valsartan, 229 taking ramipril). There was no significant difference in change in LVEF ( P =0.79) or LAV ( P =0.62) by treatment group. Patients randomized to sacubitril/valsartan demonstrated less increase in LV end-diastolic volume ( P =0.025) and greater decline in LV mass index ( P =0.037), increase in tissue Doppler e’ lat ( P =0.005), decrease in E/e’ lat ( P =0.045), and decrease in tricuspid regurgitation peak velocity ( P =0.024) than patients randomized to ramipril. These differences remained significant after adjustment for differences in baseline characteristics. Baseline LVEF, LV end-diastolic volume, LV end-systolic volume, LV mass index, LAV, and Doppler-based diastolic indices were associated with risk of cardiovascular death or incident heart failure. Conclusions: Treatment with sacubitril/valsartan compared with ramipril after AMI did not result in changes in LVEF or LAV at 8 months. Patients randomized to sacubitril/valsartan had less LV enlargement and greater improvement in filling pressure. Measures of LV size, systolic function, and diastolic properties were predictive of cardiovascular death and incident heart failure after AMI in this contemporary, well-treated cohort. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02924727.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
卡卡西完成签到,获得积分0
刚刚
刚刚
静一静完成签到,获得积分10
刚刚
传奇3应助啦啦咔嘞采纳,获得10
1秒前
南滨完成签到 ,获得积分10
1秒前
2秒前
2秒前
柳易槐完成签到,获得积分10
2秒前
666应助机智的天蓉采纳,获得10
2秒前
如意完成签到,获得积分10
2秒前
上官若男应助科研通管家采纳,获得10
3秒前
小豆豆应助科研通管家采纳,获得10
3秒前
情怀应助科研通管家采纳,获得10
3秒前
ll应助科研通管家采纳,获得10
3秒前
量子星尘发布了新的文献求助10
3秒前
英俊的铭应助科研通管家采纳,获得10
3秒前
wy.he应助科研通管家采纳,获得10
3秒前
niuade发布了新的文献求助10
3秒前
Orange应助科研通管家采纳,获得10
3秒前
wy.he应助科研通管家采纳,获得10
3秒前
顾矜应助科研通管家采纳,获得10
3秒前
3秒前
4秒前
彭于晏应助科研通管家采纳,获得10
4秒前
4秒前
脑洞疼应助科研通管家采纳,获得10
4秒前
大个应助科研通管家采纳,获得30
4秒前
ybdx完成签到,获得积分10
4秒前
EasonYan发布了新的文献求助10
4秒前
掌门发布了新的文献求助10
4秒前
5秒前
7秒前
8秒前
8秒前
yemma应助Nero采纳,获得10
8秒前
9秒前
9秒前
云是完成签到,获得积分10
10秒前
niuade完成签到,获得积分10
10秒前
FLZLC发布了新的文献求助10
11秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3969458
求助须知:如何正确求助?哪些是违规求助? 3514286
关于积分的说明 11173363
捐赠科研通 3249652
什么是DOI,文献DOI怎么找? 1794948
邀请新用户注册赠送积分活动 875501
科研通“疑难数据库(出版商)”最低求助积分说明 804836